Josh Arnold Investment Consultant’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Josh Arnold Investment Consultant’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.57M	Buy	2,464,359 +4,550	+0.2%	+$14K	6.47%	3
2025 Q4	$8.76M	Buy	2,459,809 +2,255,559	+1,104%	+$8.37M	6.53%	3
2025 Q3	$713K	Sell	204,250 -2,242,300	-92%	-$7.68M	0.57%	6
2025 Q2	$5.02M	Buy	2,446,550 +457,650	+23%	+$1.14M	4.35%	3
2025 Q1	$2.27M	Buy	+1,988,900	New	+$1.54M	1.89%	7
2024 Q1	–	Sell	-1,856,329	Closed	-$3.79M	–	24
2023 Q4	$3.79M	Sell	1,856,329 -21,143	-1%	-$36.7K	3.62%	3
2023 Q3	$2.65M	Buy	1,877,472 +819,321	+77%	+$848K	2.76%	3
2023 Q2	$582K	Buy	1,058,151 +941,308	+806%	+$498K	0.57%	11
2023 Q1	$79K	Buy	116,843 +12,443	+12%	+$15.9K	0.09%	15
2022 Q4	$172K	Buy	+104,400	New	+$293K	0.25%	14

Other funds holding STLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Josh Arnold Investment Consultant's STLN Position: Q1 2026 in Review

Josh Arnold Investment Consultant increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 0.18% in Q1 2026, buying an estimated $14K and bringing the position to 2,464,359 shares worth $7.57M. The position accounts for 6.47% of the portfolio, ranked #3.

Josh Arnold Investment Consultant first reported a position in STLN in Q4 2022 and has held it in 10 quarters since. The position peaked at $8.76M in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

Josh Arnold Investment Consultant held 2,464,359 shares of Starling Oncology Institute, Inc. Common Stock worth $7.57M as of Q1 2026.
Josh Arnold Investment Consultant bought 4,550 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $14K.
Starling Oncology Institute, Inc. Common Stock made up 6.47% of Josh Arnold Investment Consultant's portfolio in Q1 2026, its #3 holding.
Josh Arnold Investment Consultant first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2022 and has held it in 10 quarters since.
Josh Arnold Investment Consultant's Starling Oncology Institute, Inc. Common Stock position peaked at $8.76M in Q4 2025.
115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Josh Arnold Investment Consultant's 13F filing for Q1 2026, filed 15 May 2026.